SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-102294
Filing Date
2023-09-20
Accepted
2023-09-20 16:10:09
Documents
14
Period of Report
2023-09-20
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326565d1_8k.htm   iXBRL 8-K 30763
2 EXHIBIT 99.1 tm2326565d1_ex99-1.htm EX-99.1 11759
6 GRAPHIC tm2326565d1_ex99-1img001.jpg GRAPHIC 4964
  Complete submission text file 0001104659-23-102294.txt   227554

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sctl-20230920.xsd EX-101.SCH 3027
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sctl-20230920_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sctl-20230920_pre.xml EX-101.PRE 22367
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2326565d1_8k_htm.xml XML 3203
Mailing Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341
Business Address 1 E. UWCHLAN AVE, SUITE 112 EXTON PA 19341 770-534-8239
Societal CDMO, Inc. (Filer) CIK: 0001588972 (see all company filings)

IRS No.: 261523233 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36329 | Film No.: 231266606
SIC: 2834 Pharmaceutical Preparations